Aflibercept for neovascular age-related macular degeneration-Reference-Cited by-同舟云学术

Aflibercept for neovascular age-related macular degeneration

Published:2016-02-08 Issue:2 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sarwar Salman¹,Clearfield Elizabeth²,Soliman Mohamed Kamel¹,Sadiq Mohammad Ali¹,Baldwin Andrew J¹,Hanout Mostafa¹,Agarwal Aniruddha¹,Sepah Yasir J¹,Do Diana V¹,Nguyen Quan Dong¹

Affiliation:

1. University of Nebraska Medical Center; Stanley M. Truhlsen Eye Institute; 3902 Leavenworth Street Omaha Nebraska USA 68105

2. Johns Hopkins Bloomberg School of Public Health; Department of Epidemiology; 615 N. Wolfe Street Room 6014 Baltimore Maryland USA 21205

Publisher

Wiley

Subject

Pharmacology (medical)

Reference62 articles.

1. Intraocular pressure in patients with neovascular age-related macular degeneration receiving intravitreal aflibercept or ranibizumab;Freund;Ophthalmology,2015

2. Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration;Heier;Ophthalmology,2012

3. Intravitreal aflibercept versus ranibizumab for neovascular age-related macular degeneration: 52-week subgroup analyses from the combined VIEW studies;Mitchell;Clinical and Experimental Ophthalmology,2012

4. Scheduled versus pro re nata dosing in the VIEW trials;Richard;Ophthalmology,2015

5. Intravitreal aflibercept injection for neovascular age-related macular degeneration. Ninety-six week results of the VIEW studies;Schmidt-Erfurth;Ophthalmology,2014

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current developments of gene therapy in human diseases;MedComm;2024-08-16

2. An analysis of the trends in the usage of Pharmaceutical Benefits Scheme-subsidised cancer drugs in Australia from 2012 to 2022;Journal of Cancer Research and Clinical Oncology;2024-07-31

3. Novel therapeutic perspectives for wet age-related macular degeneration: RGD-modified liposomes loaded with 2-deoxy-D-glucose as a promising nanomedicine;Biomedicine & Pharmacotherapy;2024-06

4. Metabolic Regulation of Endothelial Cells: A New Era for Treating Wet Age-Related Macular Degeneration;International Journal of Molecular Sciences;2024-05-29

5. Double-dose investigation of aflibercept in neovascular age-related macular degeneration (DIANA): a real-world study;BMC Ophthalmology;2024-05-17